Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06691633 · ClinicalTrials.gov registry record · Phase 4
Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary TKA
A Phase 4 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT06691633 is a Phase 4 study that has completed, run by University of Louisville. The registered enrollment target is 150 participants.
The verdict
NCT06691633, a Phase 4 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
The goal of this prospective, randomized study is to compare the outcomes of two cohorts of patients undergoing primary Total Knee Arthroplasty (TKA) and to determine whether a single dose of methadone administered preoperatively is effective at reducing postoperative opioid usage and postoperative pain versus a control group of patients receiving standard intraoperative opioids only for primary TKA. The main questions it aims to answer are: * What is the efficacy of a single preoperative dose of methadone in reducing opioid consumption and postoperative pain in primary total knee arthroplasty? * Will the study results demonstrate the effectiveness and safety of a single preoperative dose of methadone (10 mg) in primary total knee arthroplasty in reducing postoperative opioid usage while maintaining a similar or better level of pain control when compared to a standard pain control regimen? Researchers will compare Methadone to a standard pain control regimen (Oxycodone) to see if Methadone is equivalent or more effective at reducing opioid consumption and postoperative pain in primary total knee arthroplasty Participants will: * be randomized into one of two groups * undergo a primary TKA * complete a tracking sheet documenting daily pain medicine usage and VAS pain level for the first 14 days following the TKA * return to office at 2 weeks and 6 weeks postop for follow-up * complete additional questionnaires at 2 weeks and 6 weeks postop
Interventions
- DRUG Preoperative Methadone
- DRUG Preoperative Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-02-19 |
| Est. Completion | 2024-10-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06691633
The ClinicalTrials.gov registry entry for NCT06691633 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Preoperative Methadone is the first listed.
NCT06691633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06691633 about?
NCT06691633 is a clinical study titled "Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary TKA". The goal of this prospective, randomized study is to compare the outcomes of two cohorts of patients undergoing primary Total Knee Arthroplasty (TKA) and to determine whether a single dose of methadone administered preoperatively is effective at reducing postoperative opioid usage and postoperative ...
What is the current status of trial NCT06691633?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2024-02-19. Estimated completion is 2024-10-18.
What interventions are being tested in trial NCT06691633?
The interventions under investigation include: Preoperative Methadone (DRUG), Preoperative Oxycodone (DRUG).
Who is sponsoring clinical trial NCT06691633?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.